Prior work demonstrates that 5-fluorouracil, a thymidylate synthase inhibitor, sensitizes NSCLC KRAS mutants to apoptosis via the TRAIL-mediated pathway [34]. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.